The role of early molecular predictor in transplant-eligible chronic myelogenous leukemia.

Korean J Intern Med · 2017 · PMC5214737 · PMID 28049288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At 3 months posttransplant, MR 4.5 was associated with significantly longer event-free survival and showed a trend to lower relapse rates.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.